BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 27, 2010
 |  BC Week In Review  |  Company News  |  Deals

Arch Biopartners, Emory University, University of Colorado deal

Arch subsidiary, Colorado Cancer Therapeutics Inc. acquired an option to license exclusive rights to develop and commercialize undisclosed compounds in preclinical testing to...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >